Writing this week (March 18, 2019) in the journal Nature Cell Biology, a team led by University of Wisconsin–Madison cancer researchers and MCP faculty Richard A. Anderson and Vincent Cryns reports the discovery of an unexpected regulator of the critical protein, opening the door to the development of drugs that could target it.